In this Review:
Long-term outcomes of accelerated BEP for advanced germ-cell tumours
MDT for oligometastatic prostate cancer?
Markers of docetaxel resistance in mCRPC
Diagnostic accuracy of mpMRI for prostate cancer
PSMA PET in the diagnosis of localized prostate cancer
NaF PET/CT: Interim analysis of the POPSTAR study
Pembrolizumab for the treatment of advanced urothelial cancer
2:1 schedule with sunitinib for advanced ccRCC
Prognostic implications of NLR in metastatic ccRCC treated with TKIs
68 Gallium PSMA PET for treatment planning for ccRCC
Please login below to download this issue (PDF)